Exact Sciences (NASDAQ:EXAS) reported quarterly losses of $(0.21) per share which missed the analyst consensus estimate of $(0.07) by 218.18 percent. This is a 250 percent decrease over losses of $(0.06) per share from the same period last year. The company reported quarterly sales of $878.381 million which beat the analyst consensus estimate of $860.895 million by 2.03 percent. This is a 23.12 percent increase over sales of $713.424 million the same period last year.

• No comments yet. Be the first to comment!